APA Alıntı

Benitez, J. C., Remon, J., & Besse, B. (2019). CheckMate 153 study: Are age and performance status relevant for immune checkpoint inhibitor efficacy? Transl Lung Cancer Res.

Chicago Stili Alıntı

Benitez, Jose Carlos, Jordi Remon, ve Benjamin Besse. "CheckMate 153 Study: Are Age and Performance Status Relevant for Immune Checkpoint Inhibitor Efficacy?" Transl Lung Cancer Res 2019.

MLA Alıntı

Benitez, Jose Carlos, Jordi Remon, ve Benjamin Besse. "CheckMate 153 Study: Are Age and Performance Status Relevant for Immune Checkpoint Inhibitor Efficacy?" Transl Lung Cancer Res 2019.